Navigation Links
Large-scale identification and analysis of suppressive drug interactions
Date:4/24/2014

TORONTO Baker's yeast is giving scientists a better understanding of drug interactions, which are a major cause of hospitalization and illness world-wide.

When two or more medications are taken at the same time, one can suppress or enhance the effectiveness of the other. Similarly, one drug may magnify the toxicity of another. These types of interactions are a major cause of illness and hospitalization. However, there are severe practical limits on the practical scope of drug studies in humans. Limits come in part from ethics and in part from the staggering expense. Because of the vast number of combinations of different drugs that might be prescribed together in the same patient, drug interactions in patients are not extensively studied, even in the process of reviewing new drugs for approval.

This limitation has caused researchers to turn to simpler model organisms in which to study drug interactions, enabling systematic study of drug interactions at relatively low cost, according toresearchers at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto. Dr. Frederick Roth and international colleagues published their findings after testing drugs on the simple yeast Saccharomyces cerevisiae, also known as brewer's yeast or baker's yeast.

Surprising effect

"Baker's yeast is a wonderful tool for this purpose," says Dr. Roth. "Many aspects of both yeast and human genomes have remained the same since they diverged from a common ancestor around one billion years ago. When a specific combination of drugs has a surprising effect on yeast growth there is no guarantee that it will do the same thing tohuman cells. But it does give us a general idea of how often drugs are able to enhance or suppress each other's effectiveness." Dr. Roth is a Senior Investigator at the Lunenfeld-Tanenbaum and a Professor at the University of Toronto's Donnelly Centre. He also holds a Canada Excellence Research Chair in Integrative Biology.

For this first test, the team worked with anti-fungal chemicals in a total of 440 drug pairs. They found that, in almost one fifth of the combinations, one drug reduced the effectiveness of the other drug. They also found that some drugs can have a greater tendency to suppress other drugs, while other drugs are more frequently suppressed. The same team published a related study in 2011, showing that for about one third of drug pairs tested the compounds increased each other's effectiveness. "If drug interactions are happening at anything approaching these rates in humans, we should be very concerned," Dr. Roth adds.

When one drug suppresses the effectiveness of another drug, "the patient is losing benefit from one or both drugs, while still potentially being exposed to their side effects," Dr. Roth adds. When a drug combination has an effect that is more than the sum of its parts, the patient might get too much of a good thing, and it is possible for drugs to intensify each other's toxicity as well.

"This methodology may also prove useful to explore positive types of drug interactions such as in personalized medicine," adds Dr. Jim Woodgett, Director of the Lunenfeld-Tanenbaum. "Diseases such as cancer rarely respond to single medications, and this new systematic technological approach may have the potential to allow rapid optimization of combination therapies," he notes. The study noted one example of a compound (Staurosporine) that was suppressed by acidity. This phenomenon is interesting in the context of cancer because the peculiar metabolism of cancer cells often makes the local tumour environment more acidic. It would be particularly exciting to find more anti-cancer compounds that were enhanced by acidity.


'/>"/>

Contact: Polly Thompson
pthompson@lunenfeld.ca
416-586-4800 x2046
Lunenfeld-Tanenbaum Research Institute
Source:Eurekalert

Related medicine news :

1. Soy may alleviate hot flashes in menopause, large-scale study finds
2. Human papillomavirus types do not replace others after large-scale vaccination
3. Study shows large-scale genomic testing feasible, impacts therapy
4. Endocrine Society calls for large-scale studies to evaluate testosterone therapy risks
5. Large-scale study shows power of pre-k
6. First identification of a strong oral carcinogen in smokeless tobacco
7. Spectrum Surgical Offers Surgical Instrument Identification Tape
8. Wayne State embarks on study to improve identification of women at high risk of stroke
9. Orange County’s New Suspect Identification Tools Meet Resistance from MacGregor & Collins Criminal Attorneys
10. Lyme Disease Prevention Begins with Proper Tick Identification and Timely Removal.
11. Adding Patient Photos to X-Rays May Cut Identification Errors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... Calif. (PRWEB) , ... August 18, 2017 , ... Western ... in health and education to launch the University’s new Center for Innovation on Wednesday, ... WesternU Health Education Center Lecture Hall 1, followed by a technology exhibition from 1 ...
(Date:8/19/2017)... York, New York (PRWEB) , ... August 19, ... ... Street Health has announced that it is the first organization with pending recognition ... CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live video ...
(Date:8/19/2017)... Diego, CA (PRWEB) , ... August 19, 2017 , ... ... and the KKK by saying there are two sides. There are not two sides ... a way to rationalize violence and prejudice, and the NPEIV stands against all forms ...
(Date:8/19/2017)... ... ... “Congratulations! It's A Boy! God’s Gift: A Story of Love”: a children’s book ... A Boy! God’s Gift: A Story of Love” is the creation of published authors, ... by Christian Faith Publishing, Dale Anthony and Rachael Anthony’s new book is a perfect ...
(Date:8/18/2017)... ... ... ... For Immediate Release                Contact: Julian Teixeira, ... Women Seek Sex and Relationship Advice from their Fathers ...
Breaking Medicine News(10 mins):
(Date:8/3/2017)... SAN DIEGO , Aug. 3, 2017  Opioid ... crippling diseases driving up healthcare costs and threatening outcomes, ... the lab supply and IVD industry that support them, ... health care market researcher said that drugs of abuse, ... vendors and sessions at the organization,s 69th meeting in ...
(Date:8/2/2017)... 2017 CaryRx, a next-generation full-service pharmacy, has announced ... patients in the Washington D.C. metropolitan ... providing delivery of medications through the convenience of its patient-friendly ... delivered within one hour to any location in D.C. ... this invaluable service to Washington D.C. ," says ...
(Date:7/31/2017)... 2017 7D Surgical, developer of ground breaking surgical ... 7D Surgical System to support its strategic sales plan in ... and Virginia.  7D Surgical has entered into an exclusive ... premier medical facilities within those markets. ... Spartan Medical ...
Breaking Medicine Technology: